UPDATE : Sunday, January 26, 2020
상단여백
Global diabetes group opens 5-day show in Busan
The International Diabetes Federation (IDF) 2019 conference kicked off for ...
by Lee Han-soo  |  2019-12-03 11:04
라인
LG Chem licenses in US firm’s diagnostic platform tech
LG Chem said that it has licensed in a molecular diagnostic platform techno...
by Lee Han-soo  |  2019-12-02 13:42
라인
Syntekabio views industry’s crisis as opportunity
Syntekabio said that it aims to become the world's first publicly-trade...
by Jeong Sae-im  |  2019-11-29 17:54
라인
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
S. Biomedics said that the Ministry of Food and Drug Safety has approved a ...
by Lee Han-soo  |  2019-11-29 15:42
라인
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
Daewoong Pharmaceutical said its new drug Fexuprazan will challenge the pot...
by Jeong Sae-im  |  2019-11-29 15:23
라인
Hanmi's Chinese partner to start trials for anticancer treatment
Hanmi Pharmaceutical said its Chinese partner Innovent Biologics has begun ...
by Lee Han-soo  |  2019-11-28 17:38
라인
GI Innovation licenses out immunotherapy drug candidate to Chinese firm
GI Innovation said that it has licensed out GI-101, a bispecific fusion pro...
by Lee Han-soo  |  2019-11-28 16:26
라인
Takeda's ovarian cancer drug Zejula to get insurance benefit
The government said it would grant insurance benefit to Takeda's ovaria...
by Lee Han-soo  |  2019-11-28 15:36
라인
ST Pharm submits IND application for colorectal cancer treatment in US
ST Pharm said that it has submitted an investigational new drug application...
by Lee Han-soo  |  2019-11-28 14:52
라인
New Parkinson’s drug Ongentys lands on Korea
SK Chemicals said Thursday it has won local marketing license for Ongentys ...
by Jeong Sae-im  |  2019-11-28 14:52
라인
Experts ascribe excessive diabetes hospitalization to lack of early treatment
Local diabetes experts on Wednesday stressed the need to treat diabetes at ...
by Lee Han-soo  |  2019-11-28 11:26
라인
Bristol-Myers Squibb Korea names new CEO
Bristol-Myers Squibb Korea said that it has appointed Kim Jin-young as the ...
by Lee Han-soo  |  2019-11-28 11:26
라인
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug
SK Chemicals said it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-11-27 18:24
라인
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease
Daewoong Pharmaceutical said that it has completed the phase 3 clinical tri...
by Lee Han-soo  |  2019-11-27 18:21
라인
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics
Vivozon said that it has obtained good clinical results from the U.S. phase...
by Lee Han-soo  |  2019-11-26 18:48
라인
Amgen releases analysis result showing benefits of LDL-C treatment
Amgen Korea said it has presented the analysis of its high cholesterol (LDL...
by Lee Han-soo  |  2019-11-26 17:05
라인
Roche’s flu treatment Xofluza wins approval
A new influenza treatment has arrived in Korea in over 20 years.The Ministr...
by Kim Yun-mi  |  2019-11-26 16:08
라인
Immunotherapies give hope for esophageal cancer patients
In curing esophageal cancer, there has been no treatment option other than ...
by Kim Yun-mi  |  2019-11-26 15:37
라인
GC Labcell hands over NK cell-treating tech to US lab
GC Labcell said it has transferred its natural killer (NK) cell treatment t...
by Lee Han-soo  |  2019-11-26 15:33
라인
SK Biopharm to speed up global advance through XCOPRI’s launch
SK Biopharmaceuticals will launch its antiepileptic drug, XCOPRI, in the se...
by Lee Han-soo  |  2019-11-26 14:16
여백
여백
여백
Back to Top